Chemotherapy

SAN ANTONIO — An interdisciplinary program increased the number of patients safely desensitized to chemotherapy treatment, according to data presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

NEW ORLEANS — BRAF and MEK inhibitors may showed promise as a treatment option for children and adults with histiocytic disorders, according to a presenter here.

Researchers at University of Waterloo have developed an artificial intelligence system, designed in combination with new MRI technology, to identify patients who might benefit from neoadjuvant chemotherapy for breast cancer.

NEW ORLEANS — Reduced left ventricular ejection fraction may be tied to adverse changes in muscle quality among patients with breast cancer or lymphoma undergoing cancer treatment with anthracyclines, a speaker reported.

When administering chemotherapy to a patient with recurrent glioblastoma, physicians must overcome the blood-brain barrier, an immunologic feature of the central nervous system.

Automatic calcium scoring with nongated chest CT was prognostic of major adverse and cardiotoxicity-related CV events in patients with large B-cell lymphoma undergoing anthracycline-based chemotherapy, researchers reported.

Women with diffuse large B-cell lymphoma experienced significantly longer PFS and OS when receiving chemotherapy in the afternoon compared with the morning, according to data published in JCI Insight.

An expert panel of pediatric cardiologists and oncologists issued its inaugural cardio-oncology guidelines for the management of pediatric patients receiving anticancer therapy.

The cutaneous toxicities associated with cancer checkpoint inhibitors were varied depending on the malignancy and checkpoint inhibitor used, according to a study.

The FDA granted accelerated approval to tucatinib in combination with trastuzumab for adults with RAS wild-type, HER2-positive metastatic or unresectable colorectal cancer, according to a company press release.